Jobaaj Stories- 14 May 2025
Cipla Q4: Soaring Profits, Dim Outlook? Experts Divided – Should You Buy or Sell?
Cipla's Q4 Report: Strong Profits, Cautious OutlookCipla, a major Indian pharmaceutical company, ann
- Jobaaj Stories
- 12 May 2025
TikTok's Fate, Tariffs Paused: US-China Trade Deal Shakes Markets
US-China Trade Talks and the Tariff Deal: What it Means for TikTok and Beyond The recent US-China t
- Jobaaj Stories
- 08 May 2025
Ozempic: Canadian Discovery, Global Impact – Learn More Now!
Ozempic: A Canadian Discovery, a Global PhenomenonOzempic, the blockbuster weight-loss drug, has tak
- Jobaaj Stories
- 03 Apr 2025
Trump's Tariffs Trigger Sensex Dip: IT Sector Hardest Hit
Sensex Dips Amidst Trump's Tariff Shock: IT Sector Takes a Hit The BSE Sensex closed 0.4% lower
- Jobaaj Stories
- 21 Mar 2025
Mounjaro in India: Hope for Obesity, But at What Cost?
Eli Lilly's Mounjaro in India: Hope and Concerns for Weight Loss Eli Lilly's Mounjaro, a gr
- Jobaaj Stories
- 21 Mar 2025
Mounjaro in India: Weight-Loss Hope or Health Debate?
Eli Lilly's Mounjaro: A Weight-Loss Drug in India Eli Lilly's Mounjaro, a groundbreaking we
- Jobaaj Stories
- 01 Feb 2025
In the Union Budget for FY25-26, Finance Minister Nirmala Sitharaman announced an allocation of ₹9
Explore Topics
Newsletter
Tag Clouds